Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Cardinal, T; Rutkowski, MJ; Micko, A; Shiroishi, M; Jason, Liu, CS; Wrobel, B; Carmichael, J; Zada, G.
Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Neurosurg Focus. 2020; 48(6):E10
Doi: 10.3171/2020.3.FOCUS2080
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Micko Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE: Acromegaly is a disease of acral enlargement and elevated serum levels of insulin-like growth factor-1 (IGF-1) and growth hormone (GH), usually caused by a pituitary adenoma. A lack of consensus on factors that reliably predict outcomes in acromegalic patients following endoscopic endonasal transsphenoidal surgery (EETS) warrants additional investigation. METHODS: The authors identified 52 patients with acromegaly who underwent an endoscopic endonasal approach (EEA) for resection of a GH-secreting pituitary adenoma. Preoperative and postoperative tumor and endocrinological characteristics such as tumor size, invasiveness, and GH/IGF-1 levels were evaluated as potential indicators of postoperative hormonal remission. Endocrinological remission was defined as postoperative IGF-1 levels at or below the age- and sex-normalized values. RESULTS: The 52 patients had a mean age of 50.7 ± 13.4 years and a mean follow-up duration of 24.4 ± 19.1 months. Ten patients (19%) had microadenomas and 42 (81%) had macroadenomas. Five patients (9.6%) had giant adenomas. Forty-four tumors (85%) had extrasellar extension, with 40 (77%) exhibiting infrasellar invasion, 18 (35%) extending above the sella, and 7 (13%) invading the cavernous sinuses. Thirty-six patients (69%) underwent gross-total resection (GTR; mean maximal tumor diameter 1.47 cm), and 16 (31%) underwent subtotal resection (STR; mean maximal tumor diameter 2.74 cm). Invasive tumors were significantly larger, and Knosp scores were negatively correlated with GTR. Thirty-eight patients (73%) achieved hormonal remission after EEA resection alone, which increased to 87% with adjunctive medical therapy. Ninety percent of patients with microadenomas and 86% of patients with macroadenomas achieved hormonal remission. Preoperative IGF-1 and postoperative day 1 (POD1) GH levels were inversely correlated with hormonal remission. Postoperative CSF leakage occurred in 2 patients (4%), and none experienced vision loss, death, or injury to internal carotid arteries or cranial nerves. CONCLUSIONS: Endoscopic transsphenoidal resection of GH-secreting pituitary adenomas is a safe and highly effective treatment for achieving hormonal remission and tumor control in up to 87% of patients with acromegaly when combined with postoperative medical therapy. Patients with lower preoperative IGF-1 and POD1 GH levels, with less invasive pituitary adenomas, and who undergo GTR are more likely to achieve postoperative biochemical remission.
- Find related publications in this database (using NLM MeSH Indexing)
-
Acromegaly - blood, diagnostic imaging, surgery
-
Adenoma - blood, diagnostic imaging, surgery
-
Adult - administration & dosage
-
Aged - administration & dosage
-
Basic Helix-Loop-Helix Transcription Factors - blood
-
Female - administration & dosage
-
Growth Hormone-Secreting Pituitary Adenoma - blood, diagnostic imaging, surgery
-
Human Growth Hormone - blood
-
Humans - administration & dosage
-
Insulin-Like Growth Factor I - metabolism
-
Male - administration & dosage
-
Middle Aged - administration & dosage
-
Neuroendoscopy - methods, trends
-
Postoperative Care - methods
-
Preoperative Care - methods, trends
-
Remission Induction - methods
-
Retrospective Studies - administration & dosage
-
Sphenoid Bone - diagnostic imaging, surgery
- Find related publications in this database (Keywords)
-
pituitary
-
adenoma
-
acromegaly
-
somatotroph
-
cavernous sinus
-
invasion
-
surgery
-
Knosp
-
endoscope